INTECH Investment Management’s Krystal Biotech KRYS Stock Holding History

INTECH Investment Management’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.91M	Sell	10,525 -2,995	-22%	-$895K	0.04%	456
2026 Q1	$3.49M	Buy	13,520 +3,769	+39%	+$1M	0.03%	456
2025 Q4	$2.4M	Hold	9,751	–	–	0.02%	651
2025 Q3	$1.72M	Sell	9,751 -1,227	-11%	-$184K	0.02%	858
2025 Q2	$1.51M	Sell	10,978 -1,100	-9%	-$162K	0.01%	950
2025 Q1	$2.18M	Buy	12,078 +1,239	+11%	+$208K	0.02%	702
2024 Q4	$1.7M	Buy	10,839 +3,569	+49%	+$633K	0.02%	810
2024 Q3	$1.32M	Buy	+7,270	New	+$1.4M	0.01%	656

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

INTECH Investment Management's KRYS Position: Q2 2026 in Review

INTECH Investment Management reduced its Krystal Biotech (KRYS) stake by 22% in Q2 2026, selling an estimated $895K and leaving 10,525 shares worth $3.91M. The position accounts for 0.04% of the portfolio, ranked #456.

INTECH Investment Management first reported a position in KRYS in Q3 2024 and has held it in 8 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

INTECH Investment Management held 10,525 shares of Krystal Biotech worth $3.91M as of Q2 2026.
INTECH Investment Management sold 2,995 Krystal Biotech shares in Q2 2026, an estimated $895K.
Krystal Biotech made up 0.04% of INTECH Investment Management's portfolio in Q2 2026, its #456 holding.
INTECH Investment Management first reported a position in Krystal Biotech in Q3 2024 and has held it in 8 quarters since.
423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.